Showing results (21-30 of 282) with videos related to

Sort By:
Pageof 29
Lung Cancer (Amsterdam, Netherlands)|March 9, 2025
Use of immune checkpoint inhibitors in patients with lung cancer and multiple sclerosisBelén Iglesias Martinez, Amelia Insa, Guillermo Cervera Ygual, et al.
Cancer Treatment Reviews|January 12, 2010
Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of researchAna Bosch, Pilar Eroles, Rosa Zaragoza, et al.
Familial Cancer|November 3, 2012
The deletion of exons 3-5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish familiesSarai Palanca, Inmaculada de Juan, Gema Perez-Simó, et al.
Cancer Treatment Reviews|May 11, 2013
Trastuzumab in small tumours and in elderly womenJoan Albanell, Eva M Ciruelos, Ana Lluch, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 28, 2022
A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel studyDolores Isla, Enriqueta Felip, Pilar Garrido, et al.
Molecular and Cellular Biochemistry|May 30, 2013
Epistatic interaction of Arg72Pro TP53 and -710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survivalPatricia Rodrigues, Jessica Furriol, Eduardo Tormo, et al.
Breast Cancer Research and Treatment|February 9, 2012
The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish populationPatricia Rodrigues, Jessica Furriol, Eduardo Tormo, et al.
Clinical Breast Cancer|December 4, 2003
A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancerAntonio Antón, Javier Hornedo, Ana Lluch, et al.
Plos One|January 24, 2013
Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjectsBegoña Pineda, Miguel Ángel García-Pérez, Antonio Cano, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 3, 2023
SEOM clinical guideline on heritable TP53-related cancer syndrome (2022)Ana Beatriz Sánchez-Heras, Teresa Ramon Y Cajal, Marta Pineda, et al.
Pageof 29